Levine Leichtman Capital-backed Therapeutic Research Center completed the acquisition of NetCE.

Levine Leichtman Capital-backed Therapeutic Research Center, a provider of independent, evidence-based content for recommendations and education on drug therapy and medication management, completed the acquisition of NetCE, a continuing education platform. Financial terms were not disclosed. "We are pleased to demonstrate our continued support of TRC through this transformative acquisition. The addition enhances TRC's ability to reach a broader set of healthcare professionals with an unmatched library of proprietary content to educate and impact entire care teams in the service of improved outcomes," Matthew Rich, LLCP Senior Managing Director.